http://www.rxwiki.com/fda-alerts/injectable-product-voluntarily-recalled-due-discovery-matter-vials
Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer.
To learn more visit, http://www.rxwiki.com/methotrexate
source
